Skip to main content

Binding of Organic Acids to Surface Receptors of Lymphocytes as an Immunosuppressive Mechanism in Uremia

  • Chapter
Uremic Toxins

Abstract

Some organic acids which inhibit binding of small ligands to plasma, so called protein binding inhibitors (PB-Ix), accumulate in body fluids of patients with renal failure. PB-Ix are believed to bind to sites on the surface of albumin and inhibit its detoxification, transport and reservoir functions1)2)3). They may play a wider toxic role, such as immunosuppression in uremic patients. PB-Ix have been shown to inhibit the mitogenic activity of lymphocytes4).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. T. A. Depner and P. F. Gulyassy: Plasma protein binding in uremia--Excretion and characterization of an inhibitor. Kidney International 18:86–94, 1980.

    Article  PubMed  CAS  Google Scholar 

  2. T. A. Depner, L. A. Stanfel, E. A. Jarrard and P. F. Gulyassy: Impaired plasma phenytoin binding in uremia--Effect of in vitro acidification and anion exchange resin. Nephron 25:231–237, 1980.

    Article  PubMed  CAS  Google Scholar 

  3. T. Sanaka, H. Kasai, Y. Kawashima, F. Takahashi, Y. Hayasaka, K. Ota and N. Sugino: Chemical identification of protein binding inhibitor in uremic patients. Japanese Journal of Kidney and Dialysis 14:75–81, 1983.

    Google Scholar 

  4. T. Sanaka, Y. Kawashima, F. Takahashi, etal: Suppressive effect of uremic protein binding inhibitor on cultivated lymphocytes. Japanese J Nephrology 15:1063–1069, 1983.

    Google Scholar 

  5. T. Sanaka: Protein binding inhibitor in uremia. Japanese J Circulation 17:400–409, 1985.

    Google Scholar 

  6. K. Koide, J. Touyama, N. Inoue, et al: Oral Adsorbent. Japanese J Clinician (Nihon Rinsyou in Japanese) 43:422–440, 1985.

    Google Scholar 

  7. Y. Kawashima, T. Sanaka, N. Sugino: Suppressive effect of quinolinic acid on bone marrow erythroid growth in uremia. Abstract of Symposium Uremic Toxin, Gent, 1986.

    Google Scholar 

  8. T. Sanaka and K. Ota: Lymphocyte blastformation in uremic patients.Japanese J Clin Immunol 8:881–887, 1976.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Plenum Press, New York

About this chapter

Cite this chapter

Sanaka, T. et al. (1987). Binding of Organic Acids to Surface Receptors of Lymphocytes as an Immunosuppressive Mechanism in Uremia. In: Ringoir, S., Vanholder, R., Massry, S.G. (eds) Uremic Toxins. Advances in Experimental Medicine and Biology, vol 223. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5445-1_27

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5445-1_27

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5447-5

  • Online ISBN: 978-1-4684-5445-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics